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INTRODUCTION
Allergic rhinitis (AR) is an immunologic nasal response,
primarily mediated by immunoglobulin E (IgE). It is con-
sidered as a heterogenous state, determined by genetic and
environmental interactions. Previous studies have shown the
relationships between allergies and polymorphisms in many
candidate genes such as IgE, transporters associated with
antigen processing (TAP), T cell receptors, and cytokines
and their receptors (1-5).
The inhalent antigens are presented to CD4+ T cell by
MHC class II in AR (6). However, it was suggested that
exogenous antigens can be channeled into the endogenous
pathway (MHC class I) by TAP molecules (7). Therefore, it
would be very interesting to determine the other possible
antigenic presentation pathway, mediated by TAP in AR.
TAP1 and TAP2 genes encode heterodimeric molecules in-
volved in endogenous antigen processing. Antigen peptides
are degraded from cytosolic proteins, assembled with MHC
class I heavy chain and  2-microglobulin in the endoplasmic
reticulum, and actively transported across the endoplasmic reti-
culum membrane by TAP (8, 9). It is possible that TAP gene
polymorphisms can influence the antigen peptide selection and
transport process and alter immune response regulation (2).
The TAP gene is considered to be one of the candidates
for disease susceptibility gene or one of the additional genes
conferring susceptibility. Polymorphisms of the TAP gene
have been investigated in several HLA-associated diseases
such as atopic dermatitis, asthma, rheumatoid arthritis, and
systemic lupus erythematosus (10, 11). There have been few
studies on the relationship between AR and TAP genes poly-
morphism, and it still remained controversial. Ismail et al.
(2) reported evidence of a strong association between TAP1
polymorphism and atopy in a Tunisian population. However,
Tacheuchi et al. (12) reported no association between TAP1
gene polymorphism and AR in a Japanese population. 
Until now, there has been no study on the TAP genes poly-
morphism in Korean patients with AR. Therefore, we design-
ed a case-control study to investigate the TAP1 and TAP2
polymorphisms and their association with AR in a Korean
population.
MATERIALS AND METHODS
Subjects
One hundred and ten consecutive and unrelated patients
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TAP1 and TAP2 Gene Polymorphisms in Korean Patients with 
Allergic Rhinitis
Antigen peptides are actively transported across the endoplasmic reticulum by the
transporters associated with antigen presentation (TAP). TAP genes polymorphism
could influence the selection process that determines which antigen peptides play
a role in the pathogenesis of allergic rhinitis. The aim of this study was to investigate
the association of TAP genes polymorphism with allergic rhinitis. TAP1 and TAP2
genotyping were performed on 110 allergic rhinitis patients and 107 healthy con-
trols. TAP1 polymorphic residues at codons 333 and 637, and TAP2 polymorphic
residues at codons 379, 565, 651, and 665 were analyzed by the amplification
refractory mutation system-polymerase chain reaction (ARMS-PCR). Analysis of
TAP1 gene polymorphism demonstrated decreased frequencies of Ile/Val geno-
type at codon 333, Asp/Gly genotype at codon 637, and haplotype A and B in
allergic rhinitis patients when compared to controls (p<0.05). However, there was
no significant difference in the genotype, phenotype, or allele frequencies at four
TAP2 codons between controls and allergic rhinitis patients. In conclusion, TAP1
gene polymorphism may be an important factor contributing to the genetic suscep-
tibility in the development of allergic rhinitis in the Korean population. 
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with AR were included in this study. They consisted of 40
females and 70 males, ranging in age from 5 to 72 yr old
(mean, 24.1 yr). All patients had nasal symptoms such as
watery rhinorrhea, sneezing, itching and/or nasal obstruction,
and positive skin prick tests (Allergopharma
�, Hamburg,
Germany) for one or more inhalant allergens including house
dust mites. There was no co-morbid condition such as aller-
gic asthma or atopic dermatitis. The control group consist-
ed of 107 healthy subjects with no personal or family histo-
ry of allergic diseases, cancers or genetic diseases. There were
40 females and 67 males ranging from 7-65 yr old (mean,
26.2 yr). All control subjects were negative for all nasal symp-
toms and skin prick tests. Prior to the experiment, informed
consents were obtained from all patients and controls.
DNA extraction
Heparinized peripheral venous blood (about 10 mL) was
drawn from each individual and stored at -70℃before being
used in the experiment. Genomic DNA was extracted from
leukocytes in the collected blood with the WizardTM Genom-
ic DNA purification kit (Promega, Madison, WI, U.S.A.).
ARMS-PCR
Polymorphic residues at codons 333 and 637 in TAP1,
and codons 379, 565, 651 and 665 in TAP2 were analyzed.
The dimorphic sites were: TAP1333 (A→G, Ile→Val, exon
4), TAP1637 (A→G, Asp→Gly, exon 10), TAP2379 (G→A,
Val→Ile), TAP2565 (G→A, Ala→Thr), TAP2651 (C→T,
Arg→Cys) and TAP2665 (A→G, Thr→Ala) (13). TAP1
and TAP2 polymorphism analyses were performed by the
amplification refractory mutation system-polymerase chain
reaction (ARMS-PCR), described by Newton et al. (14). Four
primers were used for each dimorphic site (Table 1). Two of
these were complementary to one of the dimorphic sites, while
the other two allele-nonspecific primers were used as an in-
ternal control. The TAP1333, TAP1637, TAP2379, TAP2565 and
TAP2665 primers were designed as described by Powis et al.
(15). The TAP2651 primers were designed as described by
Jackson et al. (16). 
Genomic DNA samples (1  L) were amplified in a 20  L
reaction mixture containing 1  L each of all four oligonu-
cleotide primers, 2  L dNTPs mix (Cat. No. BIO-39029,
London, U.K.), 1  L DNA template, and 13  L of distilled
water. A thermal cycler (GeneAmp PCR system 2400, Per-
kin Elmer, MA, U.S.A.) was used with the following speci-
fications: 94℃for 6 min; 35 cycles of 94℃for 1 min, 62℃
for 1 min and 72℃ for 1 min; there was a final 72℃ incu-
bation for 7 min. The reaction products were separated on a
2% agarose gel stained with ethidium bromide. 
Determination of genotypes and haplotypes
Genotyping of the TAP1333 was done as follows: Ile/Val if
241, 351 and 533 bp bands were visible, Ile/Ile if 241 and
533 bp bands were visible, and Val/Val if 351 and 533 bp
bands were visible (Fig. 1). Genotyping of the TAP1637 was
Codon Sequence (5′ to 3′ ) Specificity Size (bp)
TAP1
333 CCCTGCACTGAGATTTGCAGACCTCTGGAG 5′ flanking Control;  533 
GATCAGTGTCCCTCACCATGGTCACCCGGA Ile-333  Ile-333;  241
GGGCAGAAGGAAAAGCAGAGGCAGGGTCAC Val-333  Val-333;  351
ACCTGGGAACATGGACCACAGGGACAGGGT 3′ flanking 
TAP1
637 CATCTTCCCAGAATCTCCCCTATCCAGCTA 5′ flanking Control; 429
CATCTTGGCCCTTTGCTCTGCAGAGGTACA Asp-637 Asp-637; 307
ACCCCCTGACAGCTGGCTCCCAGCCTCCC Gly-637 Gly-637;  180
TGGGGAGGCATCCAATGGAACTGGATTTGG 3′ flanking 
TAP2
379 TTGGAGGGCTGCAGACCGTTCGCAGTTTTG 5′ flanking Control; 427
GAGACCTGGAACGCGCCTTGTACCTGCGCG Val-379 Val-379;  328
ACAACCACTCTGGTATCTTACCCTCCTGAT Ile-379 Ile-379;  158
ACATAGCTCCCCACGCTCTCCTGGTAGATC 3′ flanking
TAP2
565 CTCACAGTATGAACACTGCTACCTGCACAG 5′ flanking Control; 400
TGTTCTCCGGTTCTGTGAGGAACAACAGTA Thr-565 Thr-565;  161
ATCATCTTCGCAGCTCTGCAGCCCATAAAC Ala-565 Ala-565;  298
GGAGCAAGCTTACAATTTGTAGAAGATACC 3′ flanking
TAP2
651 AGAGGGAGGACGAAGGACCTACTAGTGGAA 5′ flanking Control; 471
CACCCCTTCAGCTGCAGGACTGGAATTACC Arg-651 Arg-651;  195
AGCAATCACCAGCACTGTGCGATCCCCTCA Cys-651 Cys-651;  335
GGCCTCAGTCCATCAGCCGCTGCTGCACCA 3′ flanking
TAP2
665 TTGGGGAATGGAATCCGGTGGTGTGAGGGC 5′ flanking Control; 408
CAGTGCTGGTGATTGCTCACAGGCTGCAAA  Thr-665      Thr-665; 141
CACCAGGATCTGGTGGGCGCGCTGAACTAC Ala-665 Ala-665;  326
TCAGCCGCTGCTGCACCAGGCGGGAATAGA 3′ flanking
Table 1. Oligonucleotide primers used for ARMS-PCR TAP1 and TAP2 typing
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done as follows: Asp/Gly if 180, 307 and 429 bp bands were
visible, Asp/Asp if 307 and 429 bp bands were visible, and
Gly/Gly if 180 and 429 bp bands were visible. The TAP2
genotypes were also classified using the same methods.
Four possible TAP1 haplotypes (A-D) were determined
by a combination of the dimorphic sites at codons 333 and
637. Eight possible TAP2 haplotypes (A-H) were deter-
mined by combination of four dimorphic sites at codons
379, 565, 651 and 665. We used TAP1 and TAP2 haplo-
type nomenclature as proposed by Powis et al. (15) and Jack-
son et al. (16) (Table 2).
Statistical analysis
All statistical analyses were performed with SPSS 10.0 (Chi-
cago, IL, U.S.A.). A chi-square test was used to compare the
distribution of TAP1 and TAP2 genotypes between control
and AR groups. Odds ratios (OR) with a 95% confidence
interval (CI) were calculated using the Mantel-Haenzel chi-
square test. Differences were significant if p<0.05.
RESULTS
TAP1 polymorphisms and allergic rhinitis
Three TAP1 genotypes (Ile/Ile, Ile/Val and Val/Val) were
found at codon 333 (Table 3). The Ile/Val genotype was sig-
nificantly decreased in the AR group when compared to Ile/
Ile (OR=0.32, 95% CI=0.17-0.60, p=0.001). The Val phe-
notype was significantly decreased in the AR group when
compared to the Ile phenotype (OR=0.52, 95% CI=0.30-
0.92, p=0.016). The Val allele was also significantly decreased
in AR patients when compared to the Ile allele (OR=0.48,
95% CI=0.28-0.81, p=0.003).
Three TAP1 genotypes (Asp/Asp, Asp/Gly and Gly/Gly)
were seen at codon 637 (Table 3). The Asp/Gly genotype was
significantly decreased in the AR group when compared to
Asp/Asp (OR=0.43, 95% CI=0.24-0.80, p=0.011). In AR
patients, the Gly allele was significantly decreased when com-
pared to the Asp (OR=0.62, 95% CI=0.38-1.01, p=0.04).
However, there was no difference between the two TAP1637
phenotypes, Asp and Gly. 
Four possible TAP1 haplotypes (A-D) were found in this
study (Table 4). The C and D haplotypes were significantly
less than A in the AR group (phenotype, p=0.006; allele, p=
0.0002). By combining the four haplotypes, the following
seven genotypes were found: AA, AB, AC, AD, BC, BD, and
DD. The AB (OR=0.31), AC (OR=0.08), and AD (OR=
0.13) genotypes were significantly decreased in the AR group
when compared with the AA genotype.
TAP2 polymorphisms and allergic rhinitis
There was no significant difference in the genotype, phe-
notype, and allele frequencies of TAP2 at codons 379, 565,
651 and 665 between the AR and control groups (Table 5).
The previously reported seven TAP2 haplotypes (A, B, C,
D, E, F, and G) were observed; however haplotype H (Ile379-
Thr565-Arg651-Ala665), reported by Tacheuchi et al. (17) was
not found in this study. A new haplotype (Val379-Thr565-Arg651
-Ala665) was observed in one person (controls), and we named
it as haplotype I (Table 2). By combining the eight TAP2
haplotypes, 18 genotypes could be possible from AA to FG.
However, their distributions were not different between the
AR and control group (Table 6).
Fig. 1. TAP1 codon 333 genotyping by ARMS-PCR. Four oligonu-
cleotides were included in each polymerase chain reaction mix.
Lanes 4, 6, 7, 8 and 11 consist of one control and one allele-spe-
cific 241 bp fragment defining the Ile/Ile homozygote. Lanes 1, 2,
3, 9 and 10 consist of one control and two allele-specific, smaller
fragments (241 bp and 351 bp) defining the Ile/Val heterozygote.
Lane 5 consists of one control and one allele-specific 351 bp frag-
ment defining the Val/Val homozygote.
M 1 2 3 4 5 6 7 8 9 10 11
533 bp
351 bp
241 bp
TAP1 TAP2
333
ATC GTC
637
GAC GGC
379
GTA ATA
565
GTA ATA
651
GTA ATA
665
GTA ATA
A Ile Asp A Val Ala Arg Thr
B Val Gly B Val Ala Arg Ala
C Val Asp C Ile Ala Arg Thr
D Ile Gly D Ile Thr Arg Thr
E Val Thr Arg Thr
F Val Ala Cys Thr
G Ile Ala Arg Ala
H Ile Thr Arg Ala
I Val Thr Arg Ala
Table 2. Nomenclature of TAP1 and TAP2 haplotypes828 K.R. Kim, S.H. Cho, S.J. Choi, et al.
DISCUSSION
It is well known that the major histocompatibility com-
plex (MHC) class I and II have fundamentally different anti-
gen processing pathways. The exogenous antigens such as
bacteria are degraded into antigenic peptides within the lyso-
somes. Upon fusion with endosomes, these peptides may
bind MHC II molecules (18). Finally, peptide-loaded MHC
class II molecules are delivered to the cell surface, and pre-
sented to CD4+ helper T cells. However, the endogenous
antigens such as virus and tumor antigens are degraded with-
in the proteasomes and actively transported across the endo-
plasmic reticulum membrane by TAP (8, 9). These peptides
are then assembled with the MHC class I heavy chain and
2-microglobulin. This complex is expressed on the cell sur-
face, where it is recognized by CD8+ T cells. Suto et al. (7)
suggested, however, that exogenous antigens can be channeled
into the endogenous pathway where antigen presentation is
mediated by MHC class I molecules. Therefore, TAP might
participate in both endogenous and exogenous antigen pro-
cessing. 
Because AR is a disease caused by inhalant exogenous anti-
gens such as pollens and house dust mites, the preferential
pathway of antigen processing is known to be MHC class II.
However, it would be possible that inhalant antigenic pep-
tides can be routed into the MHC class I (endogenous) path-
TAP1 Controls Allergic rhinitis Odds ratio CI* p value
Genotype (n=107) (%) (n=110) (%)
AA 29 27.1 71 64.5
AB 28 26.2 21 19.1 0.31 0.14-0.66
AC 26 24.3 5 4.5 0.08 0.02-0.24
AD 22 20.6 7 6.4 0.13 0.04-0.37
BC 0 0 2 1.8
BD 1 0.9 0 0 0 0.00-7.38
DD 1 0.9 4 3.7 1.63 0.16-41.08
Phenotype (n=107) (%) (n=110) (%)
A 104 97.2 104 94.5 0.006
B 29 27.1 23 20.9 0.76 0.41-1.52
C 26 24.3 7 6.4 0.27 0.10-0.69
D 24 22.4 11 10.0 0.46 0.20-1.04
Allele (2n=214) (%) (2n=220) (%)
A 134 62.6 175 79.5 0.0002
B 29 13.6 23 10.5 0.61 0.32-1.14
C 26 12.1 7 3.2 0.21 0.08-0.52
D 25 11.7 15 6.8 0.46 0.22-0.95
Table 4. TAP1 haplotypes in allergic rhinitis patients and controls
*, 95% confidence interval.
TAP1 Controls Allergic rhinitis Odds ratio CI* p value
Genotype (n=107) (%) (n=110) (%)
TAP1
333 Ile/Ile 54 50.5 82 74.5 0.001
Ile/Val 53 49.5 26 23.7 0.32 0.17-0.60
Val/Val 0 0 2 1.8
TAP1
637 Asp/Asp 55 51.4 76 69 0.011
Asp/Gly 50 46.7 30 27.3 0.43 0.24-0.80
Gly/Gly 2 1.9 4 3.7 1.45 0.22-11.85
Phenotype (n=107) (%) (n=110) (%)
TAP1
333 Ile 107 100 108 98.2 0.016
Val 53 49.5 28 25.5 0.52 0.30-0.92
TAP1
637 Asp 105 98.1 106 96.4 0.094
Gly 52 48.6 34 30.9 0.65 0.38-1.11
Allele (2n=214) (%) (2n=220) (%)
TAP1
333 Ile 161 75.2 190 86.4 0.003
Val 53 24.8 30 13.6 0.48 0.28-0.81
TAP1
637 Asp 160 74.8 182 82.7 0.04
Gly 54 25.2 38 17.3 0.62 0.38-1.01
Table 3. TAP1 polymorphisms in allergic rhinitis patients and controls
*, 95% confidence interval.way, involving TAP molecules in AR (2). The genes encod-
ing the two TAP subunits (TAP1 and TAP2) are located
within the MHC class II region between the DPB1 and
DQB1 loci (8, 9). Two TAP1 dimorphic sites (Ile/Val-333
and Asp/Gly-637) and five TAP2 dimorphic sites (Val/Ile-
379, Ala/Thr-565, Arg/Cys-651, Thr/Ala-665 and Stop/
Gln-687) have been widely investigated. It is possible that
these genetic variations may modify the TAP molecular struc-
tures, influencing antigen peptide selection. 
TAP gene polymorphisms have been investigated in sever-
al MHC-associated diseases (multiple sclerosis, Grave’s dis-
ease, and insulin-dependent diabetes mellitus), mostly in Cau-
casian patients (19-21). Until now, there have been few stud-
ies on AR in an Asian population. Ismail et al. (2) provided
evidence of a strong association between TAP1 polymor-
phism and atopy in a Tunisian population. Tacheuchi et al.
(12) reported no association between TAP1 gene polymor-
phism and AR in a Japanese population. Therefore, we believe
that it is one of the controversial issues in the pathogenetic
mechanism of the AR. In this study, we demonstrated a
strong association between AR and TAP1 polymorphism,
but not TAP2. In the AR group, Ile/Val at TAP1333, Asp/Gly
at TAP1637, and TAP1 haplotypes C and D were significant-
ly decreased when compared to controls. These results are
different from those of previous studies. To find any causes
of such discrepancy, we compared the results of controls in
different ethnics. In our study, a decreased TAP1 haplotype
A frequency and increased haplotype C and D frequencies
were observed when compared to the Tunisian (2) and Japa-
nese (12) controls. TAP1 haplotype D also deserves to be
mentioned. In control groups, TAP1 haplotype D was found
in 5% of Tunisians (2), 7.3% of Japanese (12). However, in
our study, TAP1 haplotype D was found in 11.7% of con-
trols. There might be the various spectrums of genetic pools
among different ethnic groups, and therefore, it may be not
meaningful to simply compare the results of genetic poly-
morphisms that have been done in different ethnic groups.
Other possible reasons for such discrepancies might be due
to multiple factors such as different phenotypic characteris-
tics, heterogeneity within groups of patients and controls,
and different genotyping methods.
In this study, we also analyzed the relationships between
TAP1 gene polymorphisms and the results of allergy tests
such as total serum IgE, and the strength and the multiplic-
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TAP2 Controls Allergic rhinitis Odds ratio CI* p value
Genotype (n=107) (%) (n=110) (%)
TAP2
379 Val/Val 84 78.5 81 73.6 0.373
Val/Ile 22 20.6 29 26.4 1.37 0.69-2.70
Ile/Ile 1 0.9 0 0
TAP2
565 Ala/Ala 89 83.2 95 86.4 0.513
Ala/Thr 18 16.8 15 13.6 0.8 0.35-1.74
Thr/Thr 0 0 0 0
TAP2
651 Arg/Arg 83 77.6 81 73.6 0.789
Arg/Cys 23 21.5 28 25.5 1.25 0.63-2.46
Cys/Cys 1 0.9 1 0.9 1.02 0.00-3.82
TAP2
665 Thr/Thr 39 36.4 41 37.3 0.548
Thr/Ala 51 47.7 57 51.8 1.06 0.57-1.98
Ala/Ala 17 15.9 12 10.9 0.67 0.26-1.72
Phenotype (n=107) (%) (n=110) (%)
TAP2
379 Val 106 99.1 110 100 0.53
Ile 23 21.5 29 26.4 1.22 0.63-2.33
TAP2
565 Ala 107 100 110 100 0.58
Thr 18 16.8 15 13.6 1.23 0.56-2.74
TAP2
651 Arg 106 99.1 109 99.1 0.60
Cys 24 22.4 29 26.4 1.18 0.62-2.24
TAP2
665 Thr 90 84.1 98 89.1 0.75
Ala 68 63.6 69 62.7 0.93 0.59-1.48
Allele (2n=214) (%) (2n=220) (%)
TAP2
379 Val 190 88.8 191 86.8 0.53
Ile 24 11.2 29 13.2 1.2 0.65-2.22
TAP2
565 Ala 196 91.6 205 93.2 0.53
Thr 18 8.4 15 6.8 0.8 0.37-1.17
TAP2
651 Arg 189 88.3 190 86.4 0.54
Cys 25 11.7 30 13.6 1.19 0.65-2.19
TAP2
665 Thr 129 60.3 139 63.2 0.53
Ala 85 39.7 81 36.8 1.13 0.75-1.70
Table 5. TAP2 polymorphisms in allergic rhinitis patients and controls
*, 95% confidence interval.ity of positive allergens in skin prick tests; however, there
was no association between them (data not shown). 
In conclusion, this study showed a meaningful association
between AR and a TAP1 polymorphism, but not TAP2.
Therefore, it is suggested that a TAP1 gene polymorphism
may be an important factor in AR pathogenesis in a Korean
population.
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